Home
/
Encompass Health Corp
/
Financials
/
Quarterly
Encompass Health Corp — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Encompass Health Corp filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2018
Jun 30, 2018
$1.07B
Aug 2, 2018
Q2
2018
Jun 30, 2017
$966.40M
Aug 2, 2018
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$1.48B
Oct 31, 2025
Q2
2025
Jun 30, 2025
$1.46B
Aug 6, 2025
Q1
2025
Mar 31, 2025
$1.46B
May 1, 2025
Q3
2025
Sep 30, 2024
$1.35B
Oct 31, 2025
Q2
2025
Jun 30, 2024
$1.30B
Aug 6, 2025
Q1
2025
Mar 31, 2024
$1.32B
May 1, 2025
Q3
2024
Sep 30, 2023
$1.21B
Nov 1, 2024
Q2
2024
Jun 30, 2023
$1.19B
Aug 6, 2024
Q1
2024
Mar 31, 2023
$1.16B
May 2, 2024
Q3
2023
Sep 30, 2022
$1.09B
Nov 1, 2023
Q2
2023
Jun 30, 2022
$1.06B
Aug 4, 2023
Q1
2023
Mar 31, 2022
$1.06B
May 3, 2023
Q3
2022
Sep 30, 2021
$1.01B
Nov 2, 2022
Q2
2022
Jun 30, 2021
$1.29B
Aug 4, 2022
Q1
2022
Mar 31, 2021
$1.23B
May 3, 2022
Q3
2021
Sep 30, 2020
$1.17B
Nov 2, 2021
Q2
2021
Jun 30, 2020
$1.07B
Aug 3, 2021
Q1
2021
Mar 31, 2020
$1.18B
May 4, 2021
Q3
2020
Sep 30, 2019
$1.16B
Nov 2, 2020
Q2
2020
Jun 30, 2019
$1.14B
Jul 31, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$126.50M
Oct 31, 2025
Q2
2025
Jun 30, 2025
$142.10M
Aug 6, 2025
Q1
2025
Mar 31, 2025
$151.50M
May 1, 2025
Q3
2025
Sep 30, 2024
$108.20M
Oct 31, 2025
Q2
2025
Jun 30, 2024
$114.10M
Aug 6, 2025
Q1
2025
Mar 31, 2024
$112.50M
May 1, 2025
Q3
2024
Sep 30, 2023
$85.30M
Nov 1, 2024
Q2
2024
Jun 30, 2023
$91.40M
Aug 6, 2024
Q1
2024
Mar 31, 2023
$87.70M
May 2, 2024
Q3
2023
Sep 30, 2022
$45.40M
Nov 1, 2023
Q2
2023
Jun 30, 2022
$48.70M
Aug 4, 2023
Q1
2023
Mar 31, 2022
$87.50M
May 3, 2023
Q3
2022
Sep 30, 2021
$100.00M
Nov 2, 2022
Q2
2022
Jun 30, 2021
$113.30M
Aug 4, 2022
Q1
2022
Mar 31, 2021
$107.30M
May 3, 2022
Q3
2021
Sep 30, 2020
$77.70M
Nov 2, 2021
Q2
2021
Jun 30, 2020
$33.50M
Aug 3, 2021
Q1
2021
Mar 31, 2020
$87.00M
May 4, 2021
Q3
2020
Sep 30, 2019
$97.60M
Nov 2, 2020
Q2
2020
Jun 30, 2019
$91.20M
Jul 31, 2020